Canadian researchers on promising path towards developing flu treatment using lipid target
A team of scientists from the RI-MUHC recently identified a target to “tone down” the hyperactive immunity to influenza infection
Dr. Donald Sheppard honoured at the McGill Alumni Association’s annual Honours and Awards banquet
The David Johnston Faculty & Staff Award recognizes his leadership in research efforts to tackle grand challenges in infections and immunity
Harnessing the body’s power in fight against cancer
Immunotherapy has provided lung cancer patients with real hope of recovery
Team from RI-MUHC and Lunenfeld-Tanenbaum Research Institute “follow a gut feeling” and discover a new stem cell
The human body has a remarkable ability to repair and renew itself. However, as we all know, our regenerative capacity quickly dwindles once we reach adulthood.
The unanticipated early origins of childhood brain cancer
Canadian researchers identify earliest traces of brain cancer long before the disease becomes symptomatic
A medical puzzle solved
With colleagues from the RI-MUHC and McGill University, Dr. Nada Jabado discovered a rare genetic mutation in a pair of patients who are brother and sister.
Anti-TB drugs can increase risk of TB re-infection
Treatment leads to changes in gut microbiota, compromising immunity
Using laser light to study how epilepsy arises in the healthy brain
Scientists at the RI-MUHC have developed a new method to study how seizures arise in the healthy brain.
RI-MUHC researcher to receive new funding from GlycoNet
Dr. Don Sheppard`s project in collaboration with The Hospital for Sick Children aims to improve the health of Canadians while generating positive economic outcomes
Three RI-MUHC teams receive funding from the CFI and Government of Quebec
Funding will “provide our researchers with the foundational infrastructure needed to become leading-edge contributors in diverse research fields,” says Martha Crago